The impact of SARS-CoV-2 infection on the surgical management of colorectal cancerlessons learned from a multicenter study in Spain

  1. Patricia Tejedor 1
  2. Vicente Simó Fernández 2
  3. Jorge Arredondo Chaves 3
  4. Irene López Rojo 4
  5. Jorge Baixauli Fons 5
  6. Luis Miguel Jiménez Gómez 6
  7. Marcos Gómez Ruiz 7
  8. Carlos Pastor Idoate 8
  9. Project Working Group
  1. 1 Hospital Central de la Defensa Gómez Ulla. Madrid, Spain
  2. 2 Hospital Universitario de León. León, Spain
  3. 3 Hospital Ciudad de Coria. Coria, Spain
  4. 4 M.D. Anderson Cancer Center. Madrid, Spain
  5. 5 Clínica Universidad de Navarra. Pamplona, Spain
  6. 6 Hospital Universitario Gregorio Marañón. Madrid, Spain
  7. 7 Hospital Universitario Marqués de Valdecilla. Santander, Spain
  8. 8 Clínica Universidad de Navarra. Madrid, Spain
Mostrar afiliaciones +
Revista:
Revista Española de Enfermedades Digestivas

ISSN: 2340-416,  1130-0108

Año de publicación: 2021

Volumen: 113

Número: 2

Páginas: 85-91

Tipo: Artículo

DOI: 10.17235/REED.2020.7460/2020 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Revista Española de Enfermedades Digestivas

Objetivos de desarrollo sostenible

Resumen

Objective: the aim of the study was to analyze the management of colorectal cancer (CRC) patients diagnosed with CRC or undergoing elective surgery during the period of the SARS-CoV-2 pandemic. Material and methods: a multicenter ambispective analysis was performed in nine centers in Spain during a four-month period. Data were collected from every patient, including changes in treatments, referrals or delays in surgeries, changes in surgical approaches, postoperative outcomes and perioperative SARS-CoV-2 status. The hospital’s response to the outbreak and available resources were categorized, and outcomes were divided into periods based on the timeline of the pandemic. Results: a total of 301 patients were included by the study centers and 259 (86 %) underwent surgery. Five hospitals went into phase III during the peak of incidence period, one remained in phase II and three in phase I. More than 60 % of patients suffered some form of change: 48 % referrals, 39 % delays, 4 % of rectal cancer patients had a prolonged interval to surgery and 5 % underwent neoadjuvant treatment. At the time of study closure, 3 % did not undergo surgery. More than 85 % of the patients were tested preoperatively for SARS-CoV-2. A total of nine patients (3 %) developed postoperative pneumonia; three of them had confirmed SARS-CoV-2. The observed surgical complications and mortality rates were similar as expected in a usual situation. Conclusions: the present multicenter study shows different patterns of response to the SARS-CoV-2 pandemic and collateral effects in managing CRC patients. Knowing these patterns could be useful for planning future changes in surgical departments in preparation for new outbreaks.

Fuente de los datos: Dialnet